Samsung Biologics Co., Ltd. announced earnings results for the year 2016. For the year, the company reported sales of 294.6 billion against 91.3 billion a year ago. Operating loss was 30.4 billion against 203.6 billion a year ago. Net loss was 176.8 billion against 1,904.9 billion a year ago.